Eli Lilly and Company

Eli Lilly and Company

LLY
Eli Lilly and CompanyUS flagNew York Stock Exchange
1,210.50
USD
+18.76
- -
1.14TMarket Cap

Valuation

Price vs. fair value · multiples
Price & Valuation BandSIGNATURE
Price against a fair-value channel (EPS × 12 / 15 / 23×)
+30.8% CAGROvervalued +187%
PriceFair value

Growth

Revenue · EPS · free cash flow
Revenue
Top line with YoY growth
+12.6% CAGR
RevenueYoY growth
EPS (Diluted)
Per-share earnings · loss years read red
+26.5% CAGR
EPSYoY growth
Free Cash Flow
Operating CF − capex, with FCF margin
Operating CFCapexFree cash flowFCF margin

Profitability

Margins & returns on capital
Gross Profit & Margin
Bars with margin trend line
+13.8% CAGR
Gross profitGross margin
Operating Income & Margin
Bars with margin trend line
+23.5% CAGR
Operating incomeOperating margin
Net Income & Margin
Loss years read red
+24.0% CAGR
Net incomeNet margin
ROIC · ROE · ROA
Returns on capital · ROE on right axis
+12.1% CAGR
ROICROEROA

Balance Sheet Health

Liquidity · leverage · share count
Cash vs. Debt
Liquidity & leverage, net-debt line
Cash & investmentsTotal debtNet debt
Shares Outstanding
Diluted share count · buybacks vs. dilution
-2.0% CAGR
Dividends & Payout Ratio
Dividend per share with payout overlay
+12.1% CAGR
Dividend / sharePayout ratio
roic.ai · Fundamentals charts. Figures are not investment advice.